Fig. 2.

ApoEdpL-W peptide prevents biofilm formation. (A) Biofilms of C. albicans strain SC5314 were developed in 96-well microtiter plates (1 h of adherence followed by 4 h of growth), exposed to increasing concentrations of ApoEdpL-W, and incubated for 24 h. The metabolic activities of biofilms were quantified using the FDA method and are shown. Data presented are from three to five replicates. Means and standard deviations are displayed. (B) Biofilms of C. albicans strain SC5314 were developed on ApoEdpL-W-coated or noncoated polyurethane and polydimethylsilloxane squares for 72 h and quantified using the FDA method. Biofilms were washed prior to quantification. Photographs show examples of the biofilms prior to washing.